Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study.

CONTEXT Previous research has suggested that activation of the renin-angiotensin-aldosterone system may promote insulin resistance and β-cell dysfunction, but the association with incident diabetes in African Americans is unknown. OBJECTIVE We examined the association of aldosterone and renin with insulin resistance, β-cell function, and incident diabetes in a large African American cohort. DESIGN The Jackson Heart Study is a prospective study of the development and progression of cardiovascular disease in African Americans. SETTING Participants were recruited from the tricounty area of metropolitan Jackson, Mississippi. PARTICIPANTS A total of 5301 African American adults, aged 21–94 years, were assessed at baseline and through 12 years of follow-up. Data on aldosterone, renin, and risk factors were collected at baseline (2000–2004). Diabetes (fasting glucose ≥ 126 mg/dL, physician diagnosis, use of diabetes drugs, or glycated hemoglobin ≥ 6.5%) was assessed at baseline and through 12 years of follow-up. Participants were excluded for missing data on baseline covariates or diabetes follow-up. Cox regression was used to estimate hazard ratios (HR) for incident diabetes using sequential modeling adjusting for age, sex, education, occupation, systolic blood pressure, current smoking, physical activity, dietary intake, and body mass index. EXPOSURES Aldosterone, renin, and diabetes risk factors were measured. OUTCOME Outcomes included the homeostatic model assessment of insulin resistance (HOMA-IR) and incident diabetes. RESULTS Among 3234 participants over a median of 8.0 years of follow-up, there were 554 cases of incident diabetes. Every 1% increase in log-transformed aldosterone was associated with a 0.18% higher log-transformed HOMA-IR in cross-sectional analyses of nondiabetic participants (P < .001). Log-transformed aldosterone and renin levels in the fifth vs first quintile were associated with a 78% (HR 1.78, 95% confidence interval 1.35–2.34) and 35% (HR 1.35, 95% confidence interval 1.06–1.72) increase in diabetes risk, respectively, in fully adjusted models. CONCLUSIONS Activation of the renin-angiotensin-aldosterone system may play a significant role in the development of insulin resistance and diabetes in African Americans.

[1]  G. Adler,et al.  Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-&ggr;, and Proinflammatory Adipokines , 2008, Circulation.

[2]  G. Adler,et al.  The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans , 2013, Current Hypertension Reports.

[3]  R. Touyz,et al.  Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction , 2012, Hypertension.

[4]  J. M. Luther Effects of aldosterone on insulin sensitivity and secretion , 2014, Steroids.

[5]  B. Egan,et al.  Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.

[6]  M. Drazner,et al.  Left Ventricular Hypertrophy Is More Prevalent in Blacks Than Whites in the General Population: The Dallas Heart Study , 2005, Hypertension.

[7]  L. Sechi,et al.  Aldosterone and the Heart: Still an Unresolved Issue? , 2014, Front. Endocrinol..

[8]  熊谷 英太 Plasma aldosterone levels and development of insulin resistance : prospective study in a general population , 2012 .

[9]  Daniel W. Jones,et al.  Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. , 2005, Ethnicity & disease.

[10]  P. Wilson,et al.  Association of Adiponectin With Left Ventricular Mass in Blacks: The Jackson Heart Study , 2011, Circulation. Heart failure.

[11]  M. Moța,et al.  Type 2 diabetes mellitus and hypertension , 2016 .

[12]  F. Beuschlein,et al.  Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. , 2013, The Journal of clinical endocrinology and metabolism.

[13]  J. Sowers,et al.  Type 2 diabetes mellitus and hypertension: an update. , 2014, Endocrinology and metabolism clinics of North America.

[14]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[15]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[16]  D. Jacobs,et al.  Plasma Aldosterone Levels and Development of Insulin Resistance: Prospective Study in a General Population , 2011, Hypertension.

[17]  M. Laakso,et al.  Effect of valsartan on the incidence of diabetes and cardiovascular events. , 2010, The New England journal of medicine.

[18]  M. Sinno,et al.  Do angiotensin converting enzyme inhibitors or angiotensin receptor blockers prevent diabetes mellitus? A meta-analysis. , 2010, Cardiology journal.

[19]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[20]  R. Vasan,et al.  Aldosterone, C-Reactive Protein, and Plasma B-Type Natriuretic Peptide Are Associated With the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components , 2013, Diabetes Care.

[21]  Sherita Hill Golden,et al.  Race/Ethnic Difference in Diabetes and Diabetic Complications , 2013, Current Diabetes Reports.

[22]  B. Falkner,et al.  Aldosterone and aldosterone: renin ratio associations with insulin resistance and blood pressure in African Americans. , 2012, Journal of the American Society of Hypertension : JASH.

[23]  L. Geiss,et al.  Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. , 2014, JAMA.

[24]  V. Basevi Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[25]  A. Barnett Type 2 diabetes and cardiovascular disease. , 2001, Nursing times.

[26]  Keith C. Norris,et al.  Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  S. Golden,et al.  Type 2 diabetes and cardiovascular disease: what next? , 2014, Current opinion in endocrinology, diabetes, and obesity.

[28]  Keith C. Norris,et al.  African Americans, hypertension and the renin angiotensin system. , 2014, World journal of cardiology.

[29]  T. Asano,et al.  High-Salt Diet Enhances Insulin Signaling and Induces Insulin Resistance in Dahl Salt-Sensitive Rats , 2002, Hypertension.

[30]  C. Grim,et al.  Biohistory of Slavery and Blood Pressure Differences in Blacks Today A Hypothesis , 1991, Hypertension.

[31]  P. Fesler,et al.  Dietary Sodium, Aldosterone, and Left Ventricular Mass Changes During Long-Term Inhibition of the Renin-Angiotensin System , 2010, Hypertension.

[32]  P. Dubbert,et al.  Dietary assessment in African Americans: methods used in the Jackson Heart Study. , 2005, Ethnicity & disease.

[33]  J. Pankow,et al.  Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. , 2011, The American journal of clinical nutrition.

[34]  A. Carriquiry,et al.  Sodium and potassium intakes among US adults: NHANES 2003-2008. , 2012, The American journal of clinical nutrition.

[35]  A. Nishiyama,et al.  Biphasic Time Course of the Changes in Aldosterone Biosynthesis Under High-Salt Conditions in Dahl Salt-Sensitive Rats , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[36]  Gregory Evans,et al.  Laboratory, Reading Center, and Coordinating Center Data Management Methods in the Jackson Heart Study , 2004, The American journal of the medical sciences.

[37]  A. Correa,et al.  High-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart Study , 2015, Diabetes Care.

[38]  B. Adams-Huet,et al.  Spironolactone Prevents Chlorthalidone-Induced Sympathetic Activation and Insulin Resistance in Hypertensive Patients , 2012, Hypertension.

[39]  Sherita Hill Golden,et al.  Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. , 2012, The Journal of clinical endocrinology and metabolism.

[40]  D. Jacobs,et al.  Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study. , 2003, American journal of epidemiology.

[41]  J. Tuomilehto,et al.  Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland , 2005, Diabetologia.

[42]  M. Tuck,et al.  The effect of aldosterone on glucose metabolism , 2003, Current hypertension reports.

[43]  L. Svetkey,et al.  Heritability of salt sensitivity in black Americans. , 1996, Hypertension.

[44]  P. Hopkins,et al.  Aldosterone production and insulin resistance in healthy adults. , 2010, The Journal of clinical endocrinology and metabolism.